Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules

PHILADELPHIA, Dec. 23, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for... Biopharmaceuticals, Generics, FDA Lannett Company
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news